Potential target identified for migraine therapy
Researchers have identified the protein GLT-1 as the neurotransmitter glutamate transporter in the brain that is related to cortical spreading depression, a pathological condition that underlies migraines. The researchers found that mice lacking GLT-1, but not other glutamate receptors, were more susceptible to cortical spreading depression than were controls. GLT-1 might therefore be a potential target for migraine therapy.
from Latest Science News -- ScienceDaily https://ift.tt/2EbRR9P
from Latest Science News -- ScienceDaily https://ift.tt/2EbRR9P
Related Posts :
Facebook Is Spending At Least $10 Billion This Year On Its Metaverse Division- Your Brain Uses 'Autocorrect' To Decipher Language and AI Just Helped Us Prove It, New Study Says
- AT&T's Confusing 5G Plus Expansion Confirms T-Mobile Was Right All Along
- Greenhouse Gas Levels Hit a New High In 2020, Even With Pandemic Lockdowns
- 'Dune' Sequel Greenlit by Legendary and Warner Bros.
0 Response to "Potential target identified for migraine therapy"
Post a Comment